Molecular Diagnostics Current Events | Molecular Diagnostics News | 5
|
| Page
5 of
15 |
287 Results |
|
|
|
Sort By:
Page Views | Date |
EMBC extends agreement with EMBO
At their recent meeting, the European Molecular Biology Conference (EMBC) voted unanimously to support the European Molecular Biology Organization's (EMBO) activities for nine further years. "This decision is particularly interesting at a time when the concept of a European Research Council is actively discussed," said Julio Celis,... view more... (2002-08-20)
Eppendorf, the Hamburg-based Biotech Group establishes competence center for biochips in Belgium.
Eppendorf AG, Hamburg, will concentrate its core activities in the business field of micro arrays (biochips) in Belgium and has acquired the majority interest in Advanced Array Technology, Namur, (AAT) effective immediately. Micro arrays are DNA probes, which are fixed to polymer supports and enable the detection of specific DNA targets. Customer... view more... (2002-07-19)
U of T researchers create microchip that can detect type and severity of cancer
U of T researchers have used nanomaterials to develop a microchip sensitive enough to quickly determine the type and severity of a patient's cancer so that the disease can be detected earlier for more effective treatment. view more (2009-09-28)
Researchers shed more light on conversion of water to hydrogen gas
Chemists are several steps closer to teasing hydrogen fuel from water using man-made molecular devices that collect electrons and use them to split hydrogen from oxygen. view more (2005-08-29)
Lein raises Significant Investment to develop Painless Test for Diabetics
Lein Applied Diagnostics Ltd, a Berkshire-based company that is developing a revolutionary new product to measure blood glucose levels in diabetics, has successfully completed a significant fundraising round through Thames Valley Investment Network (TVIN). The funding will enable Lein to produce next generation prototypes and perform clinical... view more... (2004-10-04)
Sir Hans Krebs Prize 2002 awarded to IBA Collaborator
This year's Sir Hans Krebs Prize is going to be awarded to PD Dr. med. Dirk H. Busch, Institute for Medical Microbiology, Immunology and Hygiene, Technical University Munich. The prize of Euro 10,000 is awarded by the Hannoversche Lebensversicherung a. G. for the advancement of medical basic research. Dirk Busch developed a method to functionally... view more... (2002-12-08)
Protein discovery could unlock the secret to better TB treatment
UCL scientists have found a protein that could unlock the secret to quicker, more effective treatment of TB by waking TB bacteria in the body. Once the TB bacteria are active again, the disease becomes treatable using common drugs like antibiotics. Scientists believe that uncovering the molecular structure of this protein will lead the way to... view more... (2005-02-28)
Abnormal overexpression of p53 is a predictive molecular biomarker
A common laboratory test that predicted poor outcome from traditional radiation and chemotherapy treatment for head and neck cancers now has been found to predict a good prognosis with treatment of p53 tumor suppressor gene therapy-making it potentially the first predictive biomarker test for a gene-based drug. view more (2006-09-15)
Effective solar cells and sensitive bioanalysis
The efficiency factor of solar cells is crucial for the success of generating electricity from sunlight. Systems in which light is concentrated 400-fold through lenses onto solar cells are proving to be particularly advantageous. view more (2009-06-26)
Researchers make case for standardized analysis of cardiac imaging
For accuracy's sake, medical professionals should use the same software for comparing and analyzing diagnostic heart images taken from different time periods and laboratories, a team of researchers has concluded. view more (2008-03-13)
Test for lung cancer looks for discomforting quiet among protective genes
When it is quiet - "almost too quiet" - in movies, it is a sign that something is about to go wrong for the good guys. view more (2007-09-19)
Gene profiling can single out the worst cases of multiple myeloma and guide therapy
Multiple myeloma patients vary widely in how they respond to treatment, but now researchers at the Myeloma Institute for Research and Therapy at the University of Arkansas for Medical Sciences have identified a small subset of genes whose activity could predict high-risk cases and potentially guide therapy in the future. view more (2007-09-19)
New technique for cancer screening
Current research suggests that a new technique to determine tumor methylation status can be used in archived tissue samples. view more (2009-02-24)
Cold Spring Harbor Protocols features methods for analyzing protein interactions
Cold Spring Harbor Protocols, an online journal that publishes methods used in a wide range of biology laboratories, has added over 40 new peer-reviewed protocols to its archive today. view more (2006-09-11)
UCLA scientists identify how immune cells may help predict Alzheimer's risk
What if you could test your risk for Alzheimer's disease much like your cholesterol levels - through a simple blood test? view more (2009-07-14)
NIAID describes research priorities to fight drug-resistant tuberculosis
Tuberculosis (TB) has long been one of the world's great killers. Now, forms of drug-resistant TB--multidrug (MDR) and extensively drug-resistant (XDR)--are occurring at an ominous and accelerating rate. view more (2008-04-23)
NHS set for "airline style" transformation
UK health care may soon be transformed by the introduction of new providers, just as low-cost airlines Ryanair and Easyjet have radically changed European air travel in recent years, suggests an article in this week's BMJ. view more (2004-02-05)
Most patients can be treated safely at home for deep vein thrombosis
New, effective therapies for acute deep vein thrombosis mean that most patients do not need to be admitted to hospital, according to a study in this week's BMJ. These results challenge the traditional notion that these patients must be treated in hospital and adds to the evidence that home treatment of deep vein thrombosis is now routinely... view more... (2001-05-16)
Peakadilly nv biopharmaceutical firm created
The Flanders Interuniversity Institute for Biotechnology (VIB) and Ghent University have started up a new biopharmaceutical company named Peakadilly nv. Peakadilly will develop and market a new generation of molecular diagnostics - so-called protein bio-markers - using innovative proteomics technology developed by the research group under the... view more... (2004-10-18)
New research identifies faster detection of viruses
A more specific and faster detection of viruses has been identified in new research by Trinity College Dublin's Professor of Physics, Martin Hegner at Trinity College's Centre of Research on Adaptive Nanostructures and Nanodevices (CRANN) and an international team of researchers. view more (2009-02-17)
|
|
| Page
5 of
15 |
287 Results |
|
|
|
Sort By:
Page Views | Date |
|
